Table 1.
Participant Characteristics by Primary Opioid
| Primary opioid (N=139) | F/χ2 | p-value | |||
|---|---|---|---|---|---|
|
| |||||
| Prescription opioid (n= 33) | Heroin (n= 60) | Combined (n= 46) | |||
| Sociodemographic | |||||
|
| |||||
| Age (years) | 38.3 (14.8) | 26.1 (5.4) | 28.0 (8.4) | 19.01 | <.001 |
| Female, % | 27.3 | 26.7 | 19.6 | 0.90 | .639 |
|
| |||||
| Caucasian, % (n=138) | 90.9 | 93.2 | 97.8 | ----- | -----a |
| Hispanic, % (n=126) | 0.0 | 0.0 | 10.0 | ----- | -----a |
|
| |||||
| Beyond high school, % | 90.9 | 63.3 | 58.7 | 10.44 | .005 |
| Employed, % (n=133) | 50.0 | 41.4 | 35.6 | 1.55 | .461 |
|
| |||||
| Past month opioid use, days | |||||
| Heroin use | 0.0 (0.0) | 24.7 (7.1) | 24.9 (7.8) | 183.60 | <.001 |
| Prescription opioid use | 24.0 (7.9) | 0.4 (0.8) | 13.0 (9.4) | 140.49 | <.001 |
| Other substance use disordersb, % | |||||
|
| |||||
| Alcohol | 30.3 | 23.3 | 19.6 | 1.23 | .540 |
| Benzodiazepines/other sedatives | 15.2 | 15.0 | 26.1 | 2.46 | .292 |
| Cocaine/other stimulants | 3.0 | 25.0 | 17.4 | 7.19 | .027 |
| Cannabis | 18.2 | 20.0 | 30.4 | 2.17 | .338 |
|
| |||||
| Current smoking status, % | 45.5 | 86.7 | 82.2 | 21.17 | <.001 |
| Axis I psychiatric comorbidity, % | 63.6 | 60.0 | 67.4 | 0.61 | .736 |
a
Sample was 94% Caucasian and 88% non-Hispanic; statistics were not computed for these variables due to low prevalence.
b
No participants met criteria for hallucinogen or inhalant use disorders